Integra Lifesciences Holdings (IART) EBIT Growth (3y) (2012 - 2026)
Integra Lifesciences Holdings (IART) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 75.54% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | -2.70% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | 34.83% |
| 10 | Integra Lifesciences Holdings | 1.51 Bn | 1.24 Bn | 216.98 Mn | -31.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.94% |
| Dec 31, 2025 | -30.23% |
| Sep 30, 2025 | -43.45% |
| Jun 30, 2025 | -119.42% |
| Mar 31, 2025 | -32.68% |
| Dec 31, 2024 | -15.10% |
| Sep 30, 2024 | -28.95% |
| Jun 30, 2024 | -27.21% |
| Mar 31, 2024 | -49.46% |
| Dec 31, 2023 | -11.86% |
| Sep 30, 2023 | -22.69% |
| Jun 30, 2023 | -3.88% |
| Mar 31, 2023 | 10.31% |
| Dec 31, 2022 | 23.43% |
| Sep 30, 2022 | 72.80% |
| Jun 30, 2022 | 9.21% |
| Mar 31, 2022 | 12.63% |
| Dec 31, 2021 | 19.51% |
| Sep 30, 2021 | 33.58% |
| Jun 30, 2021 | 23.34% |